Reports for APOTEX INC
Company Name
APOTEX INC
Totals |
||
Shortage reports |
3065 |
|
Actual shortage: | 231 (8%) | |
Anticipated shortage: | 16 (1%) | |
Avoided shortage: | 9 (0%) | |
Resolved: | 2809 (92%) | |
Discontinuation Reports |
356 |
|
To be discontinued: | 22 (6%) | |
Discontinued: | 334 (94%) | |
Reversed: | 0 (0%) | |
Late reports |
142 (4%) |
|
Overdue reports |
30 (11%) |
Shortage reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
APO-CEFACLOR | 500MG | CAPSULE | Actual shortage | 2017-08-13 | 2017-10-05 | 19039 |
APO-DOCUSATE CALCIUM | 240MG | CAPSULE | Actual shortage | 2017-08-14 | 2017-10-05 | 19120 |
APO-HYDROXYUREA | 500MG | CAPSULE | Resolved | 2017-08-14 | 2017-12-07 | 19129 |
APO AMPI CAPSULES 250MG | 250MG | CAPSULE | Actual shortage | 2017-08-16 | 2017-10-05 | 19582 |
APO AMPI CAPSULES 500MG | 500MG | CAPSULE | Actual shortage | 2017-08-16 | 2017-10-05 | 19589 |
APO-GABAPENTIN | 100MG | CAPSULE | Resolved | 2017-08-21 | 2017-10-04 | 20000 |
APO-DOXY CAP 100MG | 100MG | CAPSULE | Resolved | 2017-09-04 | 2017-11-16 | 20869 |
APO-QUININE | 300MG | CAPSULE | Resolved | 2017-09-04 | 2018-04-17 | 20894 |
APO-RAMIPRIL | 1.25MG | CAPSULE | Resolved | 2017-09-04 | 2017-11-09 | 20897 |
APO-RIVASTIGMINE | 1.5MG | CAPSULE | Resolved | 2017-09-04 | 2019-10-15 | 20900 |
APO-SERTRALINE | 100MG | CAPSULE | Resolved | 2017-09-04 | 2017-10-05 | 20903 |
APO-CELECOXIB | 200MG | CAPSULE | Resolved | 2017-09-26 | 2018-02-26 | 23546 |
APO-CLINDAMYCIN | 150MG | CAPSULE | Resolved | 2017-09-26 | 2017-10-12 | 23550 |
APO-PREGABALIN | 150MG | CAPSULE | Resolved | 2017-09-27 | 2017-10-30 | 23623 |
APO-PREGABALIN | 25MG | CAPSULE | Resolved | 2017-09-27 | 2018-01-19 | 23626 |
APO-PREGABALIN | 50MG | CAPSULE | Resolved | 2017-09-27 | 2018-01-19 | 23629 |
APO-RAMIPRIL | 10MG | CAPSULE | Resolved | 2017-09-27 | 2017-12-14 | 23641 |
APO-RAMIPRIL | 1.25MG | CAPSULE | Resolved | 2017-09-27 | 2017-11-09 | 23644 |
APO-SERTRALINE | 100MG | CAPSULE | Resolved | 2017-11-09 | 2018-01-31 | 28709 |
APO-GABAPENTIN | 300MG | CAPSULE | Resolved | 2017-11-09 | 2017-12-19 | 28726 |
Discontinuation reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
APO-IRBESARTAN | 300MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60539 |
APO-LAMIVUDINE | 150MG | TABLET | Discontinued | 2018-09-07 | 2019-07-13 | 60557 |
APO-LAMIVUDINE | 300MG | TABLET | Discontinued | 2018-09-07 | 2019-07-13 | 60560 |
APO-LAMIVUDINE HBV | 100MG | TABLET | Discontinued | 2018-09-07 | 2019-12-21 | 60563 |
APO-LEVOCARB - TAB 25MG/250MG | 25MG 250MG | TABLET | Discontinued | 2018-09-07 | 2019-02-07 | 60576 |
APO-LISINOPRIL | 10MG | TABLET | Discontinued | 2018-09-07 | 2019-02-02 | 60579 |
APO-LISINOPRIL | 20MG | TABLET | Discontinued | 2018-09-07 | 2018-11-26 | 60582 |
APO-LISINOPRIL | 5MG | TABLET | Discontinued | 2018-09-07 | 2019-02-13 | 60585 |
APO-LORAZEPAM | 0.5MG | TABLET | Discontinued | 2018-09-07 | 2018-12-28 | 60591 |
APO-LORAZEPAM | 1MG | TABLET | Discontinued | 2018-09-07 | 2018-10-05 | 60594 |
APO-LOSARTAN/HCTZ | 12.5MG 100MG | TABLET | Discontinued | 2018-09-07 | 2018-11-02 | 60597 |
APO-LOSARTAN/HCTZ | 25MG 100MG | TABLET | Discontinued | 2018-09-07 | 2018-12-28 | 60600 |
APO-LOSARTAN/HCTZ | 12.5MG 50MG | TABLET | Discontinued | 2018-09-07 | 2018-12-28 | 60603 |
APO-MEDROXY TABLETS | 2.5MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60609 |
APO-MELOXICAM | 7.5MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60612 |
APO-MEMANTINE | 10MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60615 |
APO-METOPROLOL | 25MG | TABLET | To be discontinued | 2018-09-07 | 2021-06-03 | 60628 |
APO-METOPROLOL | 50MG | TABLET | Discontinued | 2018-09-07 | 2019-01-09 | 60631 |
APO-METOPROLOL (TYPE L) | 50MG | TABLET | Discontinued | 2018-09-07 | 2019-02-02 | 60634 |
APO-MYCOPHENOLATE | 500MG | TABLET | Discontinued | 2018-09-07 | 2018-10-12 | 60640 |